A short-term margin squeeze
02/06/22 -"We have revised downwards our profitability expectations due to the significant price increases for consumables and single-use products. Compounded by the higher costs for energy and freight. All in ..."
Pages
65
Language
English
Published on
02/06/22
You may also be interested by these reports :
05/12/25
Against the backdrop of strong execution, with two outlook upgrades in 2025, backed by vigorous growth across all its focus areas (oncology, ...
28/11/25
Novo’s investors losing more weight than its patients
25/11/25
CureVac’s Q3 sales surpassed market expectations, driven by a one-off contribution from GSK. The operating profit benefited from the resolution of ...
25/11/25
Even though the sentiment around Novo has been extremely adverse (further exacerbated by today’s R&D development around Alzheimer’s), in our opinion, ...